Funds US-based clinical trials repurposing approved therapies to address urgent health needs of veterans and military, with a focus on mental health, PTSD, and brain injuries.
Funder: Cures Within Reach
Due Dates: May 29, 2026: Letter of Intent (LOI) submission deadline (11:59pm US Eastern Time)
Funding Amounts: Up to $75,000 per project (includes required 20% institutional match); additional $5,000–$15,000 available for community engagement
Summary: Supports clinical trials repurposing approved therapies to address urgent health needs of US veterans and military, especially mental health, PTSD, and brain injuries.
Key Information: Submission via ProposalCentral; community engagement funds available; institutional match required.
This opportunity from Cures Within Reach funds clinical repurposing trials led by US-based research institutions, aiming to improve the quality and length of life for US veterans and active military. Projects must use already approved drugs, devices, nutraceuticals, or diagnostics in new indications—specifically targeting unmet or high-priority medical needs such as mental health, post-traumatic stress disorder (PTSD), and brain injuries. The preferred focus is on proof of concept, pivotal, Phase I, or Phase IIA clinical trials, particularly those addressing unsolved diseases with limited treatment options, resistance, high cost, or significant side effects.
Eligible projects should demonstrate robust trial designs and are encouraged to include community engagement, especially for studies addressing health disparities. Community partnerships with organizations serving veterans or underrepresented populations are supported and, in some cases, required.